868 related articles for article (PubMed ID: 17482115)
21. Comparative study of fusion rate induced by different dosages of Escherichia coli-derived recombinant human bone morphogenetic protein-2 using hydroxyapatite carrier.
Lee JH; Yu CH; Yang JJ; Baek HR; Lee KM; Koo TY; Chang BS; Lee CK
Spine J; 2012 Mar; 12(3):239-48. PubMed ID: 22341396
[TBL] [Abstract][Full Text] [Related]
22. Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Wang JC; Kanim LE; Yoo S; Campbell PA; Berk AJ; Lieberman JR
J Bone Joint Surg Am; 2003 May; 85(5):905-11. PubMed ID: 12728043
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of autologous iliac crest bone graft and bone morphogenetic proteins for posterolateral fusion of lumbar spine: a meta-analysis of the results.
Papakostidis C; Kontakis G; Bhandari M; Giannoudis PV
Spine (Phila Pa 1976); 2008 Sep; 33(19):E680-92. PubMed ID: 18758349
[TBL] [Abstract][Full Text] [Related]
24. The effects of doxorubicin (adriamycin) on spinal fusion: an experimental model of posterolateral lumbar spinal arthrodesis.
Tortolani PJ; Park AE; Louis-Ugbo J; Attallah-Wasef ES; Kraiwattanapong C; Heller JG; Boden SD; Yoon ST
Spine J; 2004; 4(6):669-74. PubMed ID: 15541701
[TBL] [Abstract][Full Text] [Related]
25. Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats.
Miyazaki M; Sugiyama O; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Virk MS; Lieberman JR; Wang JC
Spine (Phila Pa 1976); 2008 Jun; 33(13):1410-7. PubMed ID: 18475244
[TBL] [Abstract][Full Text] [Related]
26. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes.
Slosar PJ; Josey R; Reynolds J
Spine J; 2007; 7(3):301-7. PubMed ID: 17482113
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of insoluble bone gelatin as a carrier for enhancement of osteogenic protein-1-induced intertransverse process lumbar fusion in a rabbit model.
Yao G; Qian Y; Chen J; Fan Y; Stoffel K; Yao F; Xu J; Zheng MH
Spine (Phila Pa 1976); 2008 Aug; 33(18):1935-42. PubMed ID: 18708925
[TBL] [Abstract][Full Text] [Related]
28. Effects of fibronectin on osteoinductive capability of fresh iliac bone marrow aspirate in posterolateral spinal fusion in rabbits.
Koga A; Tokuhashi Y; Ohkawa A; Nishimura T; Takayama K; Ryu J
Spine (Phila Pa 1976); 2008 May; 33(12):1318-23. PubMed ID: 18496343
[TBL] [Abstract][Full Text] [Related]
29. Quantitative study of parathyroid hormone (1-34) and bone morphogenetic protein-2 on spinal fusion outcomes in a rabbit model of lumbar dorsolateral intertransverse process arthrodesis.
Lina IA; Puvanesarajah V; Liauw JA; Lo SF; Santiago-Dieppa DR; Hwang L; Mao A; Bydon A; Wolinsky JP; Sciubba DM; Gokaslan Z; Holmes C; Witham TF
Spine (Phila Pa 1976); 2014 Mar; 39(5):347-55. PubMed ID: 24365898
[TBL] [Abstract][Full Text] [Related]
30. The effect of platelet-rich plasma and bone marrow on murine posterolateral lumbar spine arthrodesis with bone morphogenetic protein.
Rao RD; Gourab K; Bagaria VB; Shidham VB; Metkar U; Cooley BC
J Bone Joint Surg Am; 2009 May; 91(5):1199-206. PubMed ID: 19411469
[TBL] [Abstract][Full Text] [Related]
31. A novel application of high-dose (50kGy) gamma irradiation for demineralized bone matrix: effects on fusion rate in a rat spinal fusion model.
Alanay A; Wang JC; Shamie AN; Napoli A; Chen C; Tsou P
Spine J; 2008; 8(5):789-95. PubMed ID: 17996496
[TBL] [Abstract][Full Text] [Related]
32. Comparison of bone grafts for posterior spinal fusion in adolescent idiopathic scoliosis.
Price CT; Connolly JF; Carantzas AC; Ilyas I
Spine (Phila Pa 1976); 2003 Apr; 28(8):793-8. PubMed ID: 12698123
[TBL] [Abstract][Full Text] [Related]
33. [Experimental research on spine fusion induced by tissue engineered bone].
Li GH; Hou XK; Wu XF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Feb; 25(1):39-42. PubMed ID: 12905605
[TBL] [Abstract][Full Text] [Related]
34. Bone morphogenetic proteins for spinal fusion.
Carlisle E; Fischgrund JS
Spine J; 2005; 5(6 Suppl):240S-249S. PubMed ID: 16291119
[TBL] [Abstract][Full Text] [Related]
35. An in vitro and in vivo analysis of fibrin glue use to control bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth.
Patel VV; Zhao L; Wong P; Pradhan BB; Bae HW; Kanim L; Delamarter RB
Spine J; 2006; 6(4):397-403; discussion 404. PubMed ID: 16825045
[TBL] [Abstract][Full Text] [Related]
36. Biomimetic calcium phosphate coatings as bone morphogenetic protein delivery systems in spinal fusion.
Majid K; Tseng MD; Baker KC; Reyes-Trocchia A; Herkowitz HN
Spine J; 2011 Jun; 11(6):560-7. PubMed ID: 20097616
[TBL] [Abstract][Full Text] [Related]
37. Can TGF-beta1 and rhBMP-2 act in synergy to transform bone marrow stem cells to discogenic-type cells?
Kuh SU; Zhu Y; Li J; Tsai KJ; Fei Q; Hutton WC; Yoon ST
Acta Neurochir (Wien); 2008 Oct; 150(10):1073-9; discussion 1079. PubMed ID: 18781274
[TBL] [Abstract][Full Text] [Related]
38. Bone morphogenetic protein-2 enhances bone formation when delivered by a synthetic matrix containing hydroxyapatite/tricalciumphosphate.
Jung RE; Weber FE; Thoma DS; Ehrbar M; Cochran DL; Hämmerle CH
Clin Oral Implants Res; 2008 Feb; 19(2):188-95. PubMed ID: 18067602
[TBL] [Abstract][Full Text] [Related]
39. [Bone inductive effects of rhBMP-2 loaded porous CPC implants on spine fusion in rabbits].
Zhong R; Fei Q; Zhang J; Chen T; Liu C; Long Z; Yu R; Huang H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Feb; 23(2):231-4. PubMed ID: 19275111
[TBL] [Abstract][Full Text] [Related]
40. What bone graft substitutes should we use in post-traumatic spinal fusion?
Guerado E; Fuerstenberg CH
Injury; 2011 Sep; 42 Suppl 2():S64-71. PubMed ID: 21839997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
